Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2018 000 110.4 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | expandierte, humane, allogene, mesenchymale, adulte Stammzellen, die aus Fettgewebe gewonnen wurden. |
54 | Title of basic patent | TIGZ | Verwendung von aus Fettgewebe stammenden Stromastammzellen zur Behandlung von Fisteln |
51 | IPC main class | ICM (ICMV) | C12N 5/077 (2010.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 35/36 (2015.01), A61L 27/38 (2006.01), A61P 17/02 (2006.01) |
94 | Start of term of protection | LB | May 17, 2026 |
94 | End of term of protection | LE | May 16, 2031 |
22 | DE application date | DAT | Sep 20, 2018 |
| Date of publication of application for a certificate | OT | Nov 8, 2018 |
| Date of publication of grant of certificate | PET | Oct 31, 2024 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku, 541-0045 Osaka-shi, Osaka, JP; Universidad Autónoma de Madrid, C/Einstein 3, Madrid, ES |
74 | Representative | VTR | Maiwald GmbH, 80335 München, DE |
| Address for service | | Maiwald GmbH, 80335 München, DE |
| Due date | FT FG | May 31, 2026 Annual fee for the 21st year
Patent fees |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 60 2006 044 930.5 |
68 | EP file number of basic patent | GEAKZ | 10 17 9212.5 |
43 | Date of first publication | EVT | Nov 8, 2018 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/17/1261 2018-03-23
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/17/1261 2018-03-23
|
| Date of the first transfer into DPMAregister | EREGT | Nov 8, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 12, 2024 (Show all update days)(Hide all update days)- Nov 12, 2024
- Procedures: New representative details, New representative details, 15.05.2019: changed
- Oct 31, 2024
- Date of publication of grant of certificate: new
- Procedures: Supplementary protection certificate procedure, Certificate granted, 23.08.2024: changed
- Sep 21, 2024
- Procedures: Supplementary protection certificate procedure, Certificate granted, 23.08.2024: new
- Jul 17, 2024
- Product name: changed
- End of term of protection: new
- Due date: new
- Procedures: Supplementary protection certificate procedure, Decision to grant certificate by Patent Division, 16.07.2024: new
- Nov 8, 2018
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 3)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 7, 2022 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, 541-0045 Osaka-shi, Osaka, JP; Universidad Autónoma de Madrid, Madrid, ES |
71/73 | Previous applicant/owner | INHF | TiGenix, S.A.U., Madrid, ES, Universidad Autónoma de Madrid, Madrid, ES |
| Date of update of the procedure | REGT | Oct 8, 2022 |